Skip to main content

New Enterprise Associates 15, L.P.'s Form 4 filing

NeueHealth, Inc. (NEUE) · filed Oct 6, 2025

Accession no.
0001193125-25-232128
Filed
Oct 6, 2025, 5:48 PM ET
Trade date
Oct 2, 2025
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.89K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
New Enterprise Associates 15, L.P.CIK 0001629794Director, 10% Owner
NEA Partners 15, L.P.CIK 0001640031Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 2, 2025Common StockXIn-the-money exerciseAcquired+189,195$0.01+$1,891.951,527,217Direct
Oct 2, 2025Common StockSSaleDisposed−280$6.75−$1,8901,526,937Direct
Oct 2, 2025Common StockMOption exerciseAcquired+434,297$0.01+$4,342.971,961,234Direct
Oct 2, 2025Common StockFTax withholdingDisposed−643$6.75−$4,340.251,960,591Direct
Oct 2, 2025Common StockDReturned to the companyDisposed−1,960,591––0Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 2, 2025Common StockXIn-the-money exerciseDisposed−189,195$0.00$00Direct
Oct 2, 2025Common StockAGrant or awardAcquired+434,297––434,297Direct
Oct 2, 2025Common StockMOption exerciseDisposed−434,297$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)